Precigen (PGEN) Treasury Shares (2012 - 2025)
Precigen (PGEN) posted quarterly Treasury Shares of $2.9 million for Q1 2026, up 3592.26% year-over-year from $79000.0 in Q1 2025, and down 13.37% quarter-over-quarter from $3.4 million in Q4 2025.
Analysis
Precigen (PGEN) Treasury Shares (2012 - 2025) Analysis & Trends
Precigen (PGEN) has reported Treasury Shares for 11 consecutive years, with $2.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Treasury Shares rose 3592.26% year-over-year to $2.9 million; the TTM figure through Mar 2026 stood at $2.9 million (up 3592.26% YoY), while the FY2025 annual figure was $3.4 million, down 15.91% from the prior year.
- Treasury Shares slipped to $2.9 million in Q1 2026 per PGEN's latest filing, from $3.4 million in the prior quarter.
- Across five years, Treasury Shares topped out at $6.1 million in Q1 2024 and bottomed at $79000.0 in Q1 2025.
- Historically, Treasury Shares has averaged $1.9 million across 5 years, with a median of $961534.0 in 2023.
- Annual changes were most pronounced in 2025 — Treasury Shares sank 98.72% — and 2026, when it surged 3592.26%.
- Precigen's Treasury Shares stood at $697815.0 in 2022, then jumped by 37.79% to $961534.0 in 2023, then jumped by 316.42% to $4.0 million in 2024, then retreated by 15.91% to $3.4 million in 2025, then fell by 13.37% to $2.9 million in 2026.
- Business Quant data shows PGEN's Treasury Shares at $2.9 million in Q1 2026, $3.4 million in Q4 2025, and $1.7 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 2.72 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Precigen | 2.53 Bn | 2.53 Bn | 52.17 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 79,000.00 |
| Jun 30, 2025 | 79,000.00 |
| Mar 31, 2025 | 79,000.00 |
| Mar 31, 2025 | 79,000.00 |
| Dec 31, 2024 | 79,000.00 |
| Dec 31, 2024 | 79,000.00 |
| Jun 30, 2024 | 3.74 Mn |
| Jun 30, 2024 | 3.74 Mn |
| Mar 31, 2024 | 6.15 Mn |
| Mar 31, 2024 | 6.15 Mn |
| Jun 30, 2013 | 38.10 Mn |
| Jun 30, 2013 | 38.10 Mn |
| Dec 31, 2012 | 38.10 Mn |
| Dec 31, 2012 | 38.10 Mn |